Search Results

Background Older adults with cancer are at a higher risk for hospitalization, which can be a significant burden for patients, caregivers, and the healthcare system. 1 Recent data suggest that 34% of patients with cancer aged 66 to 75 years

compared with 36% of those without. Additionally, patients with cancer and VTE are at a 4- to 8-fold higher risk of death relative to those without cancer. 3 , 4 During hospitalization, patients with VTE have higher rates of in-hospital mortality and a

and also with acute care hospitalizations. 4 After discharge from an acute care hospitalization, patients may choose to pursue rehabilitative care in a skilled nursing facility (SNF). SNF care is considered a transitional period during which patients

, many hospitalizations are attributable to chronic conditions other than prostate cancer. For example, using the encounter-level data for 1997 through 2004, Milenkovic et al 4 found that among adults with prostate cancer, 84% of the inpatient encounters

Coronary artery disease (CAD) remains the leading cause of hospitalization in the United States, although the rate of hospitalization for CAD has declined from 77% in 2000 to 44% in 2010. 1 This decline may be due to control of risk factors

Background Measurement of functional status is recommended for all patients with advanced cancer, particularly older adults, 1 , 2 but little is known about functional status among hospitalized patients with advanced cancer and its relationship to

function and increased mortality. 2 , 13 However, data are lacking to understand how patients’ muscle mass and radiodensity are associated with their symptom burden and healthcare utilization. Hospitalized patients with advanced cancer represent a group

, prevention strategies, and newer treatment modalities for CDI. 4 – 9 Patients with cancer are particularly vulnerable to CDI, which is attributed to traditional risk factors such as age; cancer itself; hospitalization and health care exposure; chemotherapy

patient-oriented consequences associated with pancreatic cancer. The purpose of this study was to characterize disease progression by evaluating patterns of hospitalization in a large cohort of patients with pancreatic cancer. Methods Data A population

amenable to resection, or had surgically resectable disease but did not have surgery due to medical comorbidity or patient preference. Patient outcome end points collected included symptoms on initial presentation, disease-related hospitalizations